Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Therapy for Bladder Cancer”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06111235
What this trial is testing

Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

Who this might be right for
Non Muscle Invasive Bladder CancerUrologic CancerBladder Cancer+1 more
CG Oncology, Inc. 367
Large-scale testing (Phase 3)Study completedNCT00003701
What this trial is testing

Combination Chemotherapy in Treating Patients With Bladder Cancer

Who this might be right for
Bladder CancerUrethral Cancer
Eastern Cooperative Oncology Group 490
Large-scale testing (Phase 3)Active Not RecruitingNCT06462001
What this trial is testing

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaTransurethral Resection
Nottingham University Hospitals NHS Trust 500
Testing effectiveness (Phase 2)Study completedNCT00055601
What this trial is testing

Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer

Who this might be right for
Bladder Cancer
Radiation Therapy Oncology Group 97
Not applicableUnknownNCT05146635
What this trial is testing

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Who this might be right for
Bladder Cancer
Mansoura University 110
Early research (Phase 1)Looking for participantsNCT06586255
What this trial is testing

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

Who this might be right for
Urothelial Carcinoma BladderBladder Cancer
Abramson Cancer Center at Penn Medicine 10
Large-scale testing (Phase 3)UnknownNCT00146276
What this trial is testing

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional Cell
Association of Urologic Oncology (AUO) 178
Not applicableLooking for participantsNCT07424560
What this trial is testing

Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer

Who this might be right for
Bladder CancerBladder Cancer RecurrenceAdjuvant Therapy for Bladder Cancer+1 more
Zhilong Dong 400
Large-scale testing (Phase 3)Ended earlyNCT04197986
What this trial is testing

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Who this might be right for
Upper Tract Urothelial CarcinomasUrothelial Bladder Cancer
QED Therapeutics, a BridgeBio company 39
Testing effectiveness (Phase 2)Ended earlyNCT01042795
What this trial is testing

Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy

Who this might be right for
Urothelial CarcinomaBladder Cancer
University of Michigan 7
Testing effectiveness (Phase 2)Looking for participantsNCT07307456
What this trial is testing

Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Who this might be right for
Bladder Cancer
Changhai Hospital 31
Large-scale testing (Phase 3)UnknownNCT02948543
What this trial is testing

Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
University of Sydney 501
Large-scale testing (Phase 3)WithdrawnNCT07313891
What this trial is testing

Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Bladder (Urothelial, Transitional Cell) CancerUrothelial Carcinoma Bladder+1 more
Relmada Therapeutics, Inc.
Large-scale testing (Phase 3)Ended earlyNCT00384891
What this trial is testing

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Who this might be right for
Urinary Bladder DiseasesUrinary Bladder NeoplasmsUrinary Bladder Cancer+5 more
Medical Enterprises Europe B.V. 190
Large-scale testing (Phase 3)Active Not RecruitingNCT06109779
What this trial is testing

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

Who this might be right for
Biliary Tract Cancer
AstraZeneca 757
Testing effectiveness (Phase 2)Looking for participantsNCT06696742
What this trial is testing

PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
The First Affiliated Hospital with Nanjing Medical University 60
Testing effectiveness (Phase 2)Study completedNCT00777491
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

Who this might be right for
Bladder Cancer
Radiation Therapy Oncology Group 70
Testing effectiveness (Phase 2)Study completedNCT05239169
What this trial is testing

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (CCA)Intrahepatic CholangiocarcinomaHilar Cholangiocarcinoma+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 40
Large-scale testing (Phase 3)Study completedNCT01734798
What this trial is testing

Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer

Who this might be right for
Locally Advanced Bladder Cancer
Cairo University 198
Testing effectiveness (Phase 2)Ended earlyNCT02316548
What this trial is testing

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

Who this might be right for
Stage III Bladder CancerStage IV Bladder Cancer
NRG Oncology 14
Load More Results